-
During emergencies and in everyday life, labs support public health goals
Clinical laboratory diagnostics advance public health goals in communities across the country every single day. For patients facing diabetes, heart disease, liver disease, kidney disease, ... Read More -
New Report Highlights Value of Clinical Labs to U.S. Economy
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today released new economic data highlighting the contributions of clinical laboratories to the economy and the ... Read More -
Letter from Industry Stakeholders on Diagnostics Regulation Reform
-
ACLA Comments on CLIA proposed rule on Proficiency Testing
-
AIM Coalition Applauds Re-introduction of Rep. Speier’s Bill to Curb Physician Self-Referral of Ancillary Services
-
With all eyes on cancer moonshot, labs continue to prove value
In 2019, an estimated 1.7 million new cancer cases will be diagnosed in the U.S., according to the American Cancer Society. As patients and their ... Read More -
Leading a new generation of personalized medicine, LDTs must be key consideration in diagnostic reform
Lab developed tests (LDTs) are essential to health care delivery and the broader health system, helping pave the way for a new era of personalized ... Read More -
More than 60 Leading Health Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer Testing
Overly broad interpretation of national coverage determination for next generation sequencing restricts Medicare beneficiary access to vital testing and adversely impacts cancer care WASHINGTON, DC ... Read More -
ACLA Comments on Interoperability Advisory
-
ACLA Calls on CMS to Address Questionable Medicare Utilization Practices Through Stronger ‘Stark Law’ Provisions
Washington, D.C. – In a new comment letter to the Centers for Medicare & Medicaid Services (CMS), the American Clinical Laboratory Association called on the ... Read More
